Skip to main content

3 Result(s)

within A H Berger Remove this filter

and

  1. Article

    Correction to: Oncogenic RIT1 mutations in lung adenocarcinoma

    A. H. Berger, M. Imielinski, F. Duke, J. Wala, N. Kaplan, G. -X Shi… in Oncogene (2022)

    Download PDF (350 KB) View Article

  2. Article

    Open Access

    Oncogenic RIT1 mutations in lung adenocarcinoma

    Lung adenocarcinoma is comprised of distinct mutational subtypes characterized by mutually exclusive oncogenic mutations in RTK/RAS pathway members KRAS, EGFR, BRAF and ERBB2, and translocations involving ALK, RE...

    A H Berger, M Imielinski, F Duke, J Wala, N Kaplan, G-X Shi, D A Andres… in Oncogene (2014)

    Download PDF (1918 KB) View Article

  3. No Access

    Article

    BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP

    Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the t(9;22) translocation coding for the chimeric protein p210 BCR-ABL. The tumor suppressor phosphatase and tensin homolog (PTE...

    A Morotti, C Panuzzo, S Crivellaro, B Pergolizzi, U Familiari, A H Berger… in Leukemia (2014)